Big Ten CRC News and Events

The latest news and events from the Big Ten Cancer Research Consortium.

Big Ten CRC News & Events

June 2017

Quick Links: Current Trials * Submit an LOI * Join a Working Group

Across the Consortium: Current Edition

Hershock appointed to Steering Committee

The Big Ten Cancer Research Consortium recently welcomed Diane M. Hershock, MD, PhD, of Penn State Cancer Institute, as a member of its Steering Committee. Hershock is co-director for experimental therapeutics and medical director in the Clinical Trials Office at Penn State Cancer Institute.

Study tests continuation immunotherapy with chemotherapy in advanced NSCLC

Lung cancer researchers at the Indiana University Melvin and Bren Simon Cancer Center have opened a Big Ten CRC clinical trial testing the effects of immunotherapy in combination with next-line chemotherapy in patients who experienced some benefit from immunotherapy before their disease worsened.

Study evaluates safety, efficacy of durvalumab in locally advanced esophogeal cancer

A Big Ten Cancer Research Consortium study is evaluating the safety and efficacy of durvalumab (MEDI4736) following multi-modality therapy in esophageal cancer. The study will allow researchers to learn if giving durvalumab after chemoradiation and surgery will help the body's immune system keep the cancer from relapsing or recurring.

Watch your inbox soon for an invitation to the Big Ten Cancer Research Consortium Summit 2017 on Saturday, Oct. 21, at Big Ten Conference Headquarters in Chicago.

University of Michigan

Member Feature

Get to know: Ryan Alan Wilcox, MD, PhD
(pictured left)
Perspectives: Eric R. Fearon, MD, PhD (pictured right), director, University of Michigan Comprehensive Cancer Center and Emanuel N. Maisel Professor of Oncology